Olfactory dysfunction occurs in transgenic mice overexpressing human τ protein

Disorders of olfaction are among the first clinical signs of neurodegenerative diseases such as Alzheimer's disease (AD) and idiopathic Parkinson's disease (PD). In this study, we employed an odor habituation paradigm to evaluate the olfactory function of T alpha 1-3RT transgenic mice that overexpress tau, a key pathogenic protein in AD, and compared such function to that of wild-type controls who do not overexpress this protein. The T alpha 1-3RT mice, but not the controls, exhibited responses indicative of decreased olfactory function. These data lend support to the notion that tau may be involved in the pathogenesis of the olfactory dysfunction of some neurodegenerative diseases. Future studies need to similarly assess other pathogenic markers, as well as their distribution within various sectors of the brain, to determine the specificity of this phenomenon.

[1]  John A. Martin,et al.  β-Amyloid Peptide and Amyloid Precursor Proteins in Olfactory Mucosa of Patients with Alzheimer's Disease, Parkinson's Disease, and down Syndrome , 1995 .

[2]  Thomas A. Cleland,et al.  Behavioral models of odor similarity. , 2002, Behavioral neuroscience.

[3]  S. Daniel,et al.  The anterior olfactory nucleus in Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[4]  J. Trojanowski,et al.  Tau Proteins Are Abnormally Expressed in Olfactory Epithelium of Alzheimer Patients and Developmentally Regulated in Human Fetal Spinal Cord , 1993, Experimental Neurology.

[5]  H. Braak,et al.  Olfactory bulb changes in Alzheimer's disease , 2004, Acta Neuropathologica.

[6]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[7]  E. Keverne,et al.  Sex Difference in Attraction Thresholds for Volatile Odors from Male and Estrous Female Mouse Urine , 2002, Hormones and Behavior.

[8]  K. Davis,et al.  Olfactory identification deficits in relatives of Alzheimer's disease patients , 1996, Biological Psychiatry.

[9]  H. Berendse,et al.  Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell , 2001, Annals of neurology.

[10]  H. Braak,et al.  The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases , 1992, Neuroscience Research.

[11]  J Q Trojanowski,et al.  Human olfactory epithelium in normal aging, alzheimer's disease, and other neurodegenerative disorders , 1991, The Journal of comparative neurology.

[12]  Richard E. Brown,et al.  Searching for the Source of Urinary Odors of Individuality in Rodents , 1999 .

[13]  B. Hyman,et al.  α-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining , 2000, Acta Neuropathologica.

[14]  H. Braak,et al.  Pathoanatomy of Parkinson’s disease , 2000, Journal of Neurology.

[15]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[16]  Robert E. Johnston,et al.  Advances in Chemical Signals in Vertebrates , 1999, Springer US.

[17]  R. Doty.  Odor Perception in Neurodegenerative Diseases , 2003 .

[18]  A. Gloster,et al.  The T alpha 1 alpha-tubulin promoter specifies gene expression as a function of neuronal growth and regeneration in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  M. Iyo,et al.  Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for β‐CFT binding with positron emission tomography , 1999, Annals of neurology.

[20]  E. Montgomery,et al.  Abnormal performance on the PD test battery by asymptomatic first-degree relatives , 1999, Neurology.

[21]  Udo Rüb,et al.  Where Does Parkinson Disease Pathology Begin in the Brain? , 2002, Journal of neuropathology and experimental neurology.

[22]  J. Trojanowski,et al.  The Expression of α-, β-, and γ-Synucleins in Olfactory Mucosa from Patients with and without Neurodegenerative Diseases , 1999, Experimental Neurology.

[23]  R. Doty,et al.  Olfactory dysfunction in parkinsonism , 1988, Neurology.

[24]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[25]  J. Trojanowski,et al.  Transgenic Models of Tauopathies and Synucleinopathies , 1999, Brain pathology.

[26]  J. Trojanowski,et al.  Transgenic Mouse Model of Tauopathies with Glial Pathology and Nervous System Degeneration , 2002, Neuron.

[27]  R. Nitsch,et al.  Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice , 2001, Neuroreport.

[28]  G. V. Van Hoesen,et al.  Orbitofrontal cortex pathology in Alzheimer's disease. , 2000, Cerebral cortex.